Indoco Remedies
Indoco Remedies is expected to report top-line growth of 17.9% to `113cr, driven by the
domestic and export segments. The domestic formulation segment is expected to grow by
17.5% to `78cr. The company's OPM is expected to expand by 260bp to 15.6%, driven by
top-line growth. As a result, net profit is expected to increase by 55.6% to `14.3cr. We
maintain Buy on the stock with a Target Price of `541.
No comments:
Post a Comment